Refractory celiac disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dieterich W, Esslinger B, Schuppan D: Pathomechanisms in celiac disease. Int Arch Allergy Immunol 2003, 132:98–108.
Abdulkarim AS, Burgart LJ, See J, Murray JA: Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 2002, 97:2016–2021.
O’Mahony S, Howdle PD, Losowsky MS: Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996, 10:671–680.
Pink IJ, Creamer B: Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1967, 1:300–304.
Trier JS, Falchuk ZM, Carey MC, Schreiber DS: Celiac sprue and refractory sprue. Gastroenterology 1978, 75:307–316.
Bagdi E, Diss TC, Munson P, Isaacson PG: Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999, 94:260–264.
Mazzarella G, Maglio M, Paparo F, et al.: An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 2003, 52:57–62.
Karell K, Louka AS, Moodie SJ, et al.: HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003, 64:469–477.
Al-Toma A, Goerres MS, Meijer JW, et al.: Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 2006, 4:315–319.
Cellier C, Delabesse E, Helmer C, et al.: Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000, 356:203–208.
Kuitunen P, Visakorpi JK, Savilahti E, Pelkonen P: Malabsorption syndrome with cow’s milk intolerance. Clinical findings and course in 54 cases. Arch Dis Child 1975, 50:351–356.
Ghoshal UC, Ghoshal U, Misra A, Choudhuri G: Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol 2004, 4:10.
Tursi A, Brandimarte G, Giorgetti G: High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003, 98:839–843.
Fine KD, Meyer RL, Lee EL: The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997, 112:1830–1838.
Solid LM, Lie BA: Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005, 3:843–851.
Ciacci C, Mazzacca G: Unintentional gluten ingestion in celiac patients. Gastroenterology 1998, 115:243.
Goggins M, Kelleher D: Celiac disease and other nutrient related injuries to the gastrointestinal tract. Am J Gastroenterol 1994, 89(8 Suppl):S2–S17.
Kelly CP, Feighery CF, Gallagher RB, Weir DG: Diagnosis and treatment of gluten-sensitive enteropathy. Adv Intern Med 1990, 35:341–363.
Leffler DA, Dennis M, Hyett B, et al.: Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007, 5:445–450.
Vahedi K, Mascart F, Mary JY, et al.: Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003, 98:1079–1087.
Riordan SM, McIver CJ, Wakefield D, et al.: Luminal antigliadin antibodies in small intestinal bacterial overgrowth. Am J Gastroenterol 1997, 92:1335–1338.
Unsworth DJ, Walker-Smith JA: Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr 1985, 4:375–380.
Corazza GR, Biagi F, Volta U, et al.: Autoimmune enteropathy and villous atrophy in adults. Lancet 1997, 350:106–109.
Cellier C, Patey N, Mauvieux L, et al.: Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998, 114:471–481.
Carbonnel F, Grollet-Bioul L, Brouet JC, et al.: Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood 1998, 92:3879–3886.
Murray A, Cuevas EC, Jones DB, Wright DH: Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 1995, 146:509–519.
Olaussen RW, Løvik A, Tollefsen S, et al.: Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol 2005, 3:875–885.
Daum S, Ipczynski R, Heine B et al.: Therapy with budesonide in patients with refractory sprue. Digestion 2006, 73:60–68.
Barry RE: Coeliac disease and malignancy. Tijdschr Gastroenterol 1973, 16:23–34.
Hamilton JD, Chambers RA, Wynn-Williams A: Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease. Lancet 1976. 1(7971):1213–1216.
Peters TJ, Jones PE, Wells G: Analytical subcellular fractionation of jejunal biopsy specimens: enzyme activities, organelle pathology and response to gluten withdrawal in patients with coeliac disease. Clin Sci Mol Med 1978, 55:285–292.
Gillett HR, Arnott ID, McIntyre M, et al.: Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002, 122:800–805.
Wahab PJ, Crusius JB, Meijer JW, et al.: Cyclosporin in the treatment of adults with refractory coeliac disease—an open pilot study. Aliment Pharmacol Ther 2000, 14:767–774.
Rolny P, Sigurjonsdottir HA, Remotti H, et al.: Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol 1999, 94:219–225.
Goerres MS, Meijer JW, Wahab PJ, et al.: Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003, 18:487–494.
Verbeek WH, Mulder CJ, Zweegman S: Alemtuzumab for refractory celiac disease. N Engl J Med 2006, 355:1396–1397.
Al-Toma A, Goerres MS, Meijer JW, et al.: Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 2006, 4:1322–1327.